Company Filing History:
3 out of 721 
1 out of 378 
1 out of 832,843 Years Active: 2014-2020
Title: Jan Hübner: Innovator in Pharmaceutical Chemistry
Introduction
Jan Hübner is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. With a total of five patents to his name, Hübner's work has the potential to impact various therapeutic areas.
Latest Patents
Hübner's latest patents include groundbreaking inventions such as furane derivatives as inhibitors of ATAD2. This invention relates to specific furane derivatives that serve as inhibitors, along with a detailed process for their preparation and application. Another notable patent is for the 17-(1'-propenyl)-17-3′-oxidoestra-4-en-3-one derivative. This invention encompasses derivatives that are utilized in the production of medicinal products for oral contraception and the treatment of pre-, peri-, and postmenopausal complaints. These derivatives exhibit progestational properties and may also have antimineralocorticoid effects.
Career Highlights
Throughout his career, Jan Hübner has worked with esteemed organizations such as Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His experience in these companies has allowed him to refine his expertise in pharmaceutical innovations and contribute to significant advancements in the field.
Collaborations
Hübner has collaborated with notable colleagues, including Ulrich Klar and Joachim Kuhnke. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of innovative solutions in pharmaceutical research.
Conclusion
Jan Hübner's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and innovations in the industry.